SEMA4A and nonpapillary renal cell carcinoma: Analysis of publicly available TCGA data revealed that high SEMA3A expression was associated with poorer survival in clear cell renal cell carcinoma (ccRCC) (Fig. 6a), while another Semaphorin, SEMA4A was not (Supplementary Fig. 6A).